Acosta RD, Cash BD. Clinical effects of colonic cleansing for general health promotion: a systematic review. Am J Gastroenterol 2009; 104(11): 2830-2836; quiz 2837.
Alammar N, Wang L, Saberi B et al. The impact of peppermint oil on the irritable bowel syndrome: a meta-analysis of the pooled clinical data. BMC Altern Med 2019; 19(1): 21.
Altobelli E, Del Negro V, Angeletti PM et al. Low-FODMAP Diet Improves Irritable Bowel Syndrome Symptoms: A Meta-Analysis. Nutrients 2017; 9(9): 26.
Amsallem F, Sanchez S, Armoiry X et al. Effectiveness of Non-Pharmacological Interventions for Irritable Bowel Syndrome: A Systematic Review. Evid Based Complement Alternat Med 2021: 4404185.
Connell M, Shin A, James-Stevenson T et al. Systematic review and meta-analysis: Efficacy of patented probiotic, VSL#3, in irritable bowel syndrome. Neurogastroenterol Motil 2018; 30(12): e13427.
Dionne J, Ford AC, Yuan Y et al. A Systematic Review and Meta-Analysis Evaluating the Efficacy of a Gluten-Free Diet and a Low FODMAPs Diet in Treating Symptoms of Irritable Bowel Syndrome. Am J Gastroenterol 2018; 113(9): 1290-1300.
Ernst E, Posadzki P, Lee MS. Reflexology: an update of a systematic review of randomised clinical trials. Maturitas 2011; 68(2): 116-120.
Ford AC, Harris LA, Lacy BE et al. Systematic review with meta-analysis: the efficacy of prebiotics, probiotics, synbiotics and antibiotics in irritable bowel syndrome. Aliment Pharmacol Ther 2018; 48(10): 1044-1060.
Ford AC, Quigley EM, Lacy BE et al. Effect of antidepressants and psychological therapies, including hypnotherapy, in irritable bowel syndrome: systematic review and meta-analysis. Am J Gastroenterol 2014; 109(9): 1350-1365; quiz 1366.
Ford AC, Quigley EM, Lacy BE et al. Efficacy of prebiotics, probiotics, and synbiotics in irritable bowel syndrome and chronic idiopathic constipation: systematic review and meta-analysis. Am J Gastroenterol 2014; 109(10): 1547-1561; quiz 1546, 1562.
Ford AC, Vandvik PO. Irritable bowel syndrome: dietary interventions. BMJ Clin Evid 2015: 0410.
Goldenberg JZ, Brignall M, Hamilton M et al. Biofeedback for treatment of irritable bowel syndrome. Cochrane Database Syst Rev 2019; (11): CD012530.
Khanna R, MacDonald JK, Levesque BG. Peppermint oil for the treatment of irritable bowel syndrome: a systematic review and meta-analysis. J Clin Gastroenterol 2014; 48(6): 505-512.
Lasa JS, Altamirano MJ, Bracho LF et al. Efficacy and Safety of Intestinal Secretagogues for Chronic Constipation: A Systematic Review and Meta-Analysis. Arq Gastroenterol 2018; 55 (Suppl 1): 2-12.
Layer P, Andresen V, Pehl C et al. Update S3-Leitlinie Reizdarmsyndrom: Definition, Pathophysiologie, Diagnostik und Therapie. Gemeinsame Leitlinie der Deutschen Gesellschaft für Gastroenterologie, Verdauungs- und Stoffwechselkrankheiten (DGVS) und der Deutschen Gesellschaft für Neurogastroenterologie und Motilität (DGNM). AWMF-Registernr.: 021-016. Z Gastroenterol 2021; 59(12): 1323-1415.
Lee HH, Choi YY, Choi MG. The Efficacy of Hypnotherapy in the Treatment of Irritable Bowel Syndrome: A Systematic Review and Meta-analysis. J Neurogastroenterol Motil 2014; 20(2): 152-162.
Menees SB, Maneerattannaporn M, Kim HM et al. The efficacy and safety of rifaximin for the irritable bowel syndrome: a systematic review and meta-analysis. Am J Gastroenterol 2012; 107(1): 28-35; quiz 36.
Moayyedi P, Ford AC, Talley NJ et al. The efficacy of probiotics in the treatment of irritable bowel syndrome: a systematic review. Gut 2010; 59(3): 325-332.
Moayyedi P, Quigley EM, Lacy BE et al. The effect of fiber supplementation on irritable bowel syndrome: a systematic review and meta-analysis. Am J Gastroenterol 2014; 109(9): 1367-1374.
National Institute for Health and Care Excellence (NICE). Clinical practice guideline – Irritable bowel syndrome in adults: diagnosis and management. (NICE Clinical Guidelines; No. CG61). 2017.
Nunan D, Cai T, Gardener AD et al. Physical activity for treatment of irritable bowel syndrome. Cochrane Database Syst Rev 2022; (6): CD011497.
Peckham EJ, Cooper K, Roberts ER et al. Homeopathy for treatment of irritable bowel syndrome. Cochrane Database Syst Rev 2019; (9): CD009710.
Ruepert L, Quartero AO, de Wit NJ et al. Bulking agents, antispasmodics and antidepressants for the treatment of irritable bowel syndrome. Cochrane Database Syst Rev 2011; (8): CD003460.
Scaciota AC, Matos D, Rosa MM et al. Interventions for the Treatment of Irritable Bowel Syndrome: A Review of Cochrane Systematic Reviews. Arq Gastroenterol 2021; 58(1): 120-126.
Shah ED, Kim HM, Schoenfeld P. Efficacy and Tolerability of Guanylate Cyclase-C Agonists for Irritable Bowel Syndrome with Constipation and Chronic Idiopathic Constipation: A Systematic Review and Meta-Analysis. Am J Gastroenterol 2018; 113(3): 329-338.
Wang J, Yang P, Zhang L et al. A Low-FODMAP Diet Improves the Global Symptoms and Bowel Habits of Adult IBS Patients: A Systematic Review and Meta-Analysis. Front Nutr 2021; 8: 683191.
IQWiG-Gesundheitsinformationen sollen helfen, Vor- und Nachteile wichtiger Behandlungsmöglichkeiten und Angebote der Gesundheitsversorgung zu verstehen.
Ob eine der von uns beschriebenen Möglichkeiten im Einzelfall tatsächlich sinnvoll ist, kann im Gespräch mit einer Ärztin oder einem Arzt geklärt werden. Gesundheitsinformation.de kann das Gespräch mit Fachleuten unterstützen, aber nicht ersetzen. Wir bieten keine individuelle Beratung.
Unsere Informationen beruhen auf den Ergebnissen hochwertiger Studien. Sie sind von einem Team aus Medizin, Wissenschaft und Redaktion erstellt und von Expertinnen und Experten außerhalb des IQWiG begutachtet. Wie wir unsere Texte erarbeiten und aktuell halten, beschreiben wir ausführlich in unseren Methoden.